Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure

World Journal of Urology
John P Stein, Donald G Skinner

Abstract

Radical cystectomy with an appropriate lymphadenectomy remains the standard of therapy for high-grade invasive bladder cancer. This surgical approach provides the best survival rates with the lowest local recurrence rates and orthotopic diversion can be performed safely in most patients with an acceptable outcome and quality of life. Pathologic analysis of the bladder tumor and regional lymph nodes will help direct the need for adjuvant therapy in high-risk individuals. Equivalent long-term local control and survival are not seen with other forms of treatment including radiation therapy, chemotherapy, or a combination of the two. The rationale and clinical results of large, contemporary cystectomy series are presented, which provide a benchmark of outcomes with this form of surgical treatment.

References

Jul 1, 1990·The Journal of Urology·A K LevinsonK I Wishnow
Sep 1, 1990·The Journal of Urology·S W Hardeman, M S Soloway
Jan 1, 1994·The Journal of Urology·C L AmlingD F Paulson
Nov 1, 1996·The Journal of Urology·J A FreemanD G Skinner
Jun 17, 1998·The Journal of Urology·K ColleselliG Bartsch
Aug 28, 1998·The Journal of Urology·J P SteinR J Cote
Jul 20, 1999·The Journal of Urology·J E Montie
Feb 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J P SteinD G Skinner
Aug 8, 2001·The Journal of Urology·S S ChangJ A Smith
Jun 21, 2002·European Urology·Arnulf StenzlHermann Rogatsch
Dec 13, 2002·The Urologic Clinics of North America·John P SteinDonald G Skinner
Feb 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephan MadersbacherUrs E Studer
Aug 29, 2003·The New England Journal of Medicine·H Barton GrossmanE David Crawford
May 1, 1956·Cancer·G R PROUT, V F MARSHALL
Oct 11, 2003·Urology·John P Stein
Jan 10, 2004·The Journal of Urology·Marcus L QuekDonald G Skinner
Feb 21, 2004·CA: a Cancer Journal for Clinicians·Ahmedin JemalUNKNOWN American Cancer Society
Apr 13, 2004·The Journal of Urology·Amnon VazinaSeth P Lerner
Jun 18, 2004·The Journal of Urology·Mohamed Abdel-LatifMohamed A Ghoneim
Jul 13, 2004·The Journal of Urology·John P SteinDonald G Skinner
May 3, 2005·The Urologic Clinics of North America·John P Stein, Donald G Skinner

❮ Previous
Next ❯

Citations

Nov 22, 2007·World Journal of Urology·Ashok K HemalPankaj Wadhwa
Mar 30, 2012·World Journal of Urology·Eric Yi-Hsiu HuangSiamak Daneshmand
Dec 31, 2009·Journal of Endourology·Satya AllaparthiK C Balaji
Jun 15, 2011·Japanese Journal of Clinical Oncology·Gou KanekoMototsugu Oya
Aug 24, 2012·Japanese Journal of Clinical Oncology·Tohru NakagawaHiroyuki Fujimoto
Apr 1, 2009·Therapeutic Advances in Urology·Laurence Klotz
Jun 23, 2009·Drugs·Neeraj Agarwal, Maha Hussain
Dec 10, 2013·World Journal of Urology·Georg BartschDavid F Penson
Mar 29, 2014·Der Urologe. Ausg. A·M M HeckR Nawroth
Sep 3, 2014·Journal of Laparoendoscopic & Advanced Surgical Techniques. Part a·Scott TobisKevin Chan
Jul 22, 2011·World Journal of Surgical Oncology·Berna Aytac, Hakan Vuruskan
Apr 1, 2010·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Tanja LangsenlehnerKarin S Kapp
Jan 1, 2009·Journal of Robotic Surgery·Aldrin J GamboaDavid K Ornstein
Jul 14, 2007·Expert Review of Anticancer Therapy·John C KeferSteven C Campbell
Oct 31, 2006·Expert Review of Anticancer Therapy·Aude Flechon, Jean-Pierre Droz
Sep 26, 2007·Expert Review of Anticancer Therapy·Amir SherifN Peter Wiklund
Mar 29, 2014·Expert Opinion on Drug Discovery·Paula A OliveiraCarmen Vasconcelos-Nóbrega
Jan 22, 2015·Expert Opinion on Drug Metabolism & Toxicology·Vivek Narayan, David Vaughn
Apr 7, 2010·Scandinavian Journal of Urology and Nephrology·Tomas JerlströmMalcolm Carringer
May 13, 2015·International Journal of Oncology·Masashi MatsushimaMototsugu Oya
Dec 3, 2014·The Kaohsiung Journal of Medical Sciences·Sait OzbirCetin Dinçel
Jan 29, 2013·Pharmacology & Therapeutics·Colm J O'RourkeAntoinette S Perry
Dec 16, 2011·Urologic Oncology·Carmen Vasconcelos-NóbregaPaula A Oliveira
Jan 29, 2016·BioMed Research International·Giovanni CochettiEttore Mearini
Jan 20, 2009·The Journal of Urology·Sandip M PrasadJim C Hu
Dec 30, 2008·Urologic Oncology·Harry HerrDavid P Wood
Sep 9, 2008·Urologic Oncology·John C Kefer, Steven C Campbell
Sep 2, 2008·Surgical Oncology·Riccardo AutorinoRodolfo Montironi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.